HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Y 41654

a tumor necrosis factor-alpha convertase inhibitor

Also Known As:

Y-41654; Y41654

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Hydroxylamines: 16
    - Hydroxamic Acids: 239
      - Y 41654: 1
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Hydroxamic Acids: 239
      - Y 41654: 1
  - Acyclic Acids
    - Dicarboxylic Acids: 108
      - Succinates: 13
        Y 41654: 1

Experts

1.	Endo, Yoshihiko: 1 article (11/2009)
2.	Fujishima, Seitaro: 1 article (11/2009)
3.	Hasegawa, Naoki: 1 article (11/2009)
4.	Ishizaka, Akitoshi: 1 article (11/2009)
5.	Koh, Hidefumi: 1 article (11/2009)
6.	Nakano, Yasushi: 1 article (11/2009)
7.	Nishimura, Tomoyasu: 1 article (11/2009)
8.	Shimada, Hisato: 1 article (11/2009)
9.	Shimizu, Mie: 1 article (11/2009)
10.	Shiraishi, Yoshiki: 1 article (11/2009)

Related Diseases

1.	Acute Lung Injury 11/01/2009 - "We studied the effects of TNF-converting enzyme inhibition with Y-41654, which down-regulates the production of soluble TNF-alpha (sTNF-alpha), on acute lung injury induced by intratracheal administration of LPS. "

Related Drugs and Biologics

1.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2.	Enzymes